July 12, 2018 Hippocampal Volume as an Enrichment Biomarker in Trials of Patients with Mild Cognitive Impairment
July 12, 2018 Facilitating rapid data and information sharing by establishing a sustainable, integrated, and standardized platform advancing knowledge to enable expedited drug development
June 29, 2018 Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference Jane Larkindale, Executive Director of D-RSC, attended the Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference in...
June 24, 2018 Completing Patient-Reported Outcome Measures Electronically: A Review of the Literature on Subject Burden in Clinical Trials
April 28, 2018 Dr. Stephenson’s presentation at University of Texas Health, San Antonio, The Perry and Ruby Stevens Parkinson’s Disease Center of Excellence: “Critical Path for Parkinson’s Collaboration to Enable Patient Focused Drug Development and Precision Medicine”
November 3, 2018 D-RSC presents poster on advancing drug development for Duchenne through data sharing and quantitative tool development at the 2018 MDA Clinical Conference
February 20, 2018 2018 ISCTM Distinguished Poster Award Winner: “Global Regulatory Agencies Support Dopamine Transporter Neuroimaging in Clinical Trials Targeting Parkinson’s disease”
Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure
December 8, 2017 Characterizing Disease Progression for Parkinson’s Disease to implement efficient trial designs
December 8, 2017 Model-Informed Biomarker Qualification: Alzheimer and Parkinson Disease Imaging Biomarkers